Riva-Risperidone (2021-10-07)
- Starting date:
- October 7, 2021
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type I
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-76621
Last updated:
2021-10-12
Summary
-
Product:
Riva-Risperidone
Reason
The affected lot may contain Riva-Gabapentin 100mg capsules, however it is labelled as Riva-Risperidone 0.25mg tablets.
Depth of distribution
Wholesalers, Retailers
Affected products
Riva-Risperidone
DIN, NPN, DIN-HIM
DIN 02283565
Dosage form
Tablet
Strength
Risperidone 0.25 mg
Lot or serial number
C9323
Companies
- Recalling Firm
-
Laboratoire Riva Inc.
660 Industrial Blvd.
Blainville
J7C 3V4
Quebec
CANADA
- Marketing Authorization Holder
-
Laboratoire Riva Inc.
660 Industrial Blvd.
Blainville
J7C 3V4
Quebec
CANADA